Immunology of leprosy

Area of Science:

• Immunology
• Infectious Diseases
• Dermatology

Background:

• Leprosy, caused by Mycobacterium leprae (ML), exhibits varied clinical manifestations tied to host immune responses.
• Peripheral neural damage, leading to sensory/motor loss and deformities, often accompanies skin lesions.
• The Th1/Th2 spectrum classically describes leprosy, with Th1 correlating to limited and Th2 to disseminated forms.

Purpose of the Study:

• To discuss the Th1/Th2 dichotomy in leprosy within the context of current immunological knowledge.
• To explore the roles of cytokines, T helper (Th) subpopulations, and regulatory T cells in different leprosy presentations.
• To highlight the challenges posed by the lack of an adequate diagnostic serological test for leprosy eradication.

Main Methods:

• Review and discussion of existing literature on the immunology of leprosy.
• Analysis of the roles of cytokines, Th subpopulations, and regulatory T cells in leprosy pathogenesis.
• Examination of the limitations of current diagnostic tools for leprosy in endemic regions.

Main Results:

• The Th1/Th2 spectrum provides a framework but requires integration with current understanding of immune cell dynamics.
• Leprosy reactions involve increased inflammatory activity, exacerbating symptoms in both limited and disseminated forms.
• The absence of a reliable serological test remains a significant barrier to diagnosing leprosy in endemic areas.

Conclusions:

• A comprehensive understanding of immune responses, including T cell subsets and cytokines, is crucial for understanding leprosy's diverse presentations.
• Leprosy reactions represent significant inflammatory events that worsen patient outcomes.
• Development of an effective serological diagnostic test is essential for the global eradication of leprosy.